SEC Form D · filed March 9, 2017
Arix Bioscience plc
Industry
Other Health Care
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
David U'Prichard · LONDON, United KingdomDirectorFranz Humer · LONDON, United KingdomDirectorJohn Mutton Of Furness · LONDON, United KingdomDirectorJohn Banham · LONDON, United KingdomDirectorTrevor Jones · LONDON, United KingdomDirectorJonathan Peacock · LONDON, United KingdomExec · DirectorJames Rawlingson · LONDON, United KingdomExec · DirectorChristopher Evans · LONDON, United KingdomExec · DirectorJoseph Anderson · LONDON, United KingdomExec · DirectorJohn E. Decooman · Vancouver, British Columbia, CanadaDirectorHernan M. Zaballa · Vancouver, British Columbia, CanadaExec · DirectorCarlos E. Ponte · Vancouver, British Columbia, CanadaExec · DirectorPatrick E. Williams · La Veta, COExec · DirectorDavid E. Doherty · Vancouver, British Columbia, CanadaDirectorZula E. Kropivnitski · Vancouver, British Columbia, CanadaDirectorWillem Fuchter · Vancouver, British Columbia, CanadaDirectorCassandra E. Gee · Vancouver, British Columbia, CanadaExec · DirectorEduardo E. Perlicz · Vancouver, British Columbia, CanadaDirectorGlenn E. Martin · Tucson, AZExec · DirectorNicole M. Breen · Tucson, AZExec · DirectorYosef Katz · Cedarhurst, NYExec · DirectorMoshe Schreiber · Cedarhurst, NYDirectorAnthony Young · Los Angeles, CADirectorRyan Krafft · Sherborn, MADirectorLindsey Krystofiak · SAN FRANCISCO, CADirectorThomas E. Willingham · Richmond, VADirectorAslam Merchant · ATLANTA, GAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗